BYDUREON XUSPEN Trademark

Trademark Overview

On Wednesday, June 20, 2012, a trademark application was filed for BYDUREON XUSPEN with the United States Patent and Trademark Office. The USPTO has given the BYDUREON XUSPEN trademark a serial number of 85656606. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 25, 2014. This trademark is owned by Amylin Pharmaceuticals, Inc.. The BYDUREON XUSPEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, and diabetes; pre-filled medical injection pens for drug delivery filled with pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, and diabetes
bydureon xuspen

General Information

Serial Number85656606
Word MarkBYDUREON XUSPEN
Filing DateWednesday, June 20, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 25, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, and diabetes; pre-filled medical injection pens for drug delivery filled with pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, and diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 28, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmylin Pharmaceuticals, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmylin Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, August 25, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 25, 2014ABANDONMENT - NO USE STATEMENT FILED
Monday, March 24, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 24, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 13, 2014EXTENSION 2 GRANTED
Thursday, December 12, 2013EXTENSION 2 FILED
Thursday, December 12, 2013TEAS EXTENSION RECEIVED
Tuesday, August 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2013EXTENSION 1 GRANTED
Monday, July 1, 2013EXTENSION 1 FILED
Thursday, August 15, 2013RESPONSE TO ITU OFFICE ACTION ENTERED
Thursday, August 15, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 2, 2013ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Friday, July 26, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 1, 2013TEAS EXTENSION RECEIVED
Wednesday, May 29, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 22, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 27, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 27, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 31, 2012ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 24, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 24, 2012ASSIGNED TO LIE
Wednesday, October 10, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 10, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, October 10, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 10, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, October 10, 2012EXAMINERS AMENDMENT -WRITTEN
Friday, October 5, 2012ASSIGNED TO EXAMINER
Thursday, June 28, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 23, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

xuspen bydureon disorders pharmaceutical preparations conditions filled diabetes endocrine metabolic treatment prevention